SequelSEC

LABCORP HOLDINGS INC. LH

Services-Medical Laboratories · CIK 0000920148 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$14.35B
Fiscal year ended 2026-06-30
Operating income
$1.50B
Fiscal year ended 2026-06-30
Free cash flow
$1.16B
Fiscal year ended 2026-06-30

LABCORP HOLDINGS INC. (LH) reported revenue of $14.35B and net income of $1.00B for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from LABCORP HOLDINGS INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.

Income

LABCORP HOLDINGS INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$14.35B
Cost of revenue$10.20B
Gross profit$4.14B
Operating income$1.50B
Net income$1.00B
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expense$230.20M
Diluted EPSUnavailable
Selling, general & administrative$2.22B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

LABCORP HOLDINGS INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$141.80M
Total assets$18.53B
Current assets$3.81B
Total liabilities$9.91B
Current liabilities$2.12B
Total equity incl. NCI$8.61B
Temporary (mezzanine) equityUnavailable
Inventory$562.20M
Accounts receivable$2.34B
Goodwill$7.03B
Long-term debt$5.86B
Accounts payable$688.50M

Cash flow

LABCORP HOLDINGS INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$1.64B
Capital expenditures$483.20M
Investing cash flow-$1.45B
Financing cash flow-$689.30M
Net change in cash-$505.50M
Stock-based compensation$125.50M
Common dividends paid$239.10M
Common share repurchases$701.80M
Depreciation & amortization$696.30M

Derived

LABCORP HOLDINGS INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$1.16B
Gross margin28.9%
Operating margin10.4%
FCF margin8.1%
SBC / revenue0.9%
Current ratio1.80x
Revenue YoY growth6.4%
Net margin7.0%
R&D / revenueUnavailable
CapEx / revenue3.4%
Long-term debt / equity0.68x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-04View SEC filing
10-K · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-01View SEC filing
10-Q · Filed 2025-04-29View SEC filing

Companies in the same industry

ACON ADVB AMS BDSX BGLC BLLN CAI CDNA CELC CFOR CSTL DGX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.